Literature DB >> 5848333

Biological properties of streptococcal cell-wall particles. I. Determinants of the chronic nodular lesion of connective tissue.

J H Schwab.   

Abstract

Schwab, John H. (University of North Carolina, Chapel Hill). Biological properties of streptococcal cell-wall particles. I. Determinants of the chronic nodular lesion of connective tissue. J. Bacteriol. 90:1405-1411. 1965.-The capacity of cell-wall fragments to induce a chronic remittent nodular lesion after a single injection into rabbit skin varies qualitatively as well as quantitatively among the streptococci. This variation among strains is the result of a summation of several properties of the bacterial cell, some intrinsic and others extrinsic to the cell-wall structure. With some species, the inability to produce this lesion may be related to the susceptibility of cell walls to lysozyme. Other factors defined in this paper include production of hyaluronidase, and association of the cell walls with a component which can affect the interval between injection and appearance of the nodules, called the latent time. Separation of cell-wall fragments from more soluble cell material by centrifugation results in a shorter latent time. Addition of the soluble supernatant fraction back to the cell walls prolongs the latent time and increases the area of lesion involvement. This latter effect is due to a spreading factor present in most cell extracts. Addition of hyaluronidase to isolated cell-wall fragments duplicates the increased lesion area but tends to shorten further the latent time. Thus, the soluble cell extract contains both a spreading factor and a component which prolongs the latent time, and the final influence on the lesion is in part a product of these two activities. The ease and extent of mechanical disintegration of the cell wall can also vary widely among strains and yield cell extracts differing in their content of cell-wall fragments of optimal size.

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5848333      PMCID: PMC315828          DOI: 10.1128/jb.90.5.1405-1411.1965

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  7 in total

1.  IMMUNOLOGICAL PROPERTIES OF BACTERIAL CELL WALL MUCOPEPTIDES.

Authors:  E M ABDULLA; J H SCHWAB
Journal:  Proc Soc Exp Biol Med       Date:  1965-02

2.  The effect of a toxic cellular component of group A streptococci on connective tissue.

Authors:  W J CROMARTIE; J H SCHWAB; J G CRADDOCK
Journal:  Am J Pathol       Date:  1960-07       Impact factor: 4.307

3.  Biological properties of streptococcal cell-wall particles. II. Purification by density gradient column electrophoresis.

Authors:  J H Schwab
Journal:  J Bacteriol       Date:  1965-11       Impact factor: 3.490

4.  Relation of particle size of C polysaccharide complexes of group A streptococci to toxic effects on connective tissue.

Authors:  B S ROBERSON; J H SCHWAB; W J CROMARTIE
Journal:  J Exp Med       Date:  1960-11-01       Impact factor: 14.307

5.  ANALYSIS OF THE EXPERIMENTAL LESION OF CONNECTIVE TISSUE PRODUCED BY A COMPLEX OF C POLYSACCHARIDE FROM GROUP A STREPTOCOCCI. II. INFLUENCE OF AGE AND HYPERSENSITIVITY.

Authors:  J H SCHWAB
Journal:  J Exp Med       Date:  1964-03-01       Impact factor: 14.307

6.  Identification of a toxic cellular component of group A streptococci as a complex of group-specific C polysaccharide and a protein.

Authors:  J H SCHWAB; W J CROMARTIE; B S ROBERSON
Journal:  J Exp Med       Date:  1959-01-01       Impact factor: 14.307

7.  Immunological studies on a C polysaccharide complex of group A streptococci having a direct toxic effect on connective tissue.

Authors:  J H SCHWAB; W J CROMARTIE
Journal:  J Exp Med       Date:  1960-03-01       Impact factor: 14.307

  7 in total
  28 in total

1.  [Biological activity of bacterial peptidoglycan (mucopeptide) (author's transl)].

Authors:  B Heymer
Journal:  Klin Wochenschr       Date:  1975-01-15

2.  Effects of streptococcal cell wall fragments on phagocytosis and tissue culture cells.

Authors:  J M Jones; J H Schwab
Journal:  Infect Immun       Date:  1970-03       Impact factor: 3.441

Review 3.  Rheumatoid arthritis: review of searches for an infectious cause. Part II.

Authors:  E Wilkes; E S Meek
Journal:  Infection       Date:  1979       Impact factor: 3.553

4.  The interaction of leukocytes and their hydrolases with bacteria in vitro and in vivo: the modification of the bactericidal and bacteriolytic reactions by cationic and anionic macromolecular substances and by anti-inflammatory agents.

Authors:  I Ginsburg; M Lahav; N Ne'eman; Z Duchan; S Chanes; M N Sela
Journal:  Agents Actions       Date:  1976-02

5.  Modulation of complement fixation and the phlogistic capacity of group A, B, and D streptococci by human lysozyme acting on their cell walls.

Authors:  J K Spitznagel; K J Goodrum; D J Warejcka; J L Weaver; H L Miller; L Babcock
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

6.  Degradation of group A streptococcal cell walls by egg-white lysozyme and human lysosomal enzymes.

Authors:  A D Glick; J M Ranhand; R M Cole
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441

7.  Association of experimental chronic arthritis with the persistence of group A streptococcal cell walls in the articular tissue.

Authors:  J H Schwab; W J Cromartie; S H Ohanian; J G Craddock
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

8.  Electron microscopy of group A streptococci after phagocytosis by human monocytes.

Authors:  A D Glick; R A Getnick; R M Cole
Journal:  Infect Immun       Date:  1971-12       Impact factor: 3.441

Review 9.  Molecular Mimicry, Autoimmunity, and Infection: The Cross-Reactive Antigens of Group A Streptococci and their Sequelae.

Authors:  Madeleine W Cunningham
Journal:  Microbiol Spectr       Date:  2019-07

10.  Protective study with a group A streptococcal M protein vaccine. Infectivity challenge of human volunteers.

Authors:  E N Fox; R H Waldman; M K Wittner; A A Mauceri; A Dorfman
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.